Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 20

1.

A general inefficacy interim monitoring rule for randomized clinical trials.

Freidlin B, Korn EL, Gray R.

Clin Trials. 2010 Jun;7(3):197-208. doi: 10.1177/1740774510369019. Epub 2010 Apr 27.

PMID:
20423925
2.

Randomized clinical trials with biomarkers: design issues.

Freidlin B, McShane LM, Korn EL.

J Natl Cancer Inst. 2010 Feb 3;102(3):152-60. doi: 10.1093/jnci/djp477. Epub 2010 Jan 14.

3.

Bayesian statistics in oncology: a guide for the clinical investigator.

Adamina M, Tomlinson G, Guller U.

Cancer. 2009 Dec 1;115(23):5371-81. doi: 10.1002/cncr.24628. Review.

4.

Bayesian clinical trials at the University of Texas M. D. Anderson Cancer Center.

Biswas S, Liu DD, Lee JJ, Berry DA.

Clin Trials. 2009 Jun;6(3):205-16. doi: 10.1177/1740774509104992.

5.

Multi-arm clinical trials of new agents: some design considerations.

Freidlin B, Korn EL, Gray R, Martin A.

Clin Cancer Res. 2008 Jul 15;14(14):4368-71. doi: 10.1158/1078-0432.CCR-08-0325. Review.

6.

A randomized study of clofarabine versus clofarabine plus low-dose cytarabine as front-line therapy for patients aged 60 years and older with acute myeloid leukemia and high-risk myelodysplastic syndrome.

Faderl S, Ravandi F, Huang X, Garcia-Manero G, Ferrajoli A, Estrov Z, Borthakur G, Verstovsek S, Thomas DA, Kwari M, Kantarjian HM.

Blood. 2008 Sep 1;112(5):1638-45. doi: 10.1182/blood-2007-11-124602. Epub 2008 Jun 18.

7.

Randomized phase II study of gemcitabine and docetaxel compared with gemcitabine alone in patients with metastatic soft tissue sarcomas: results of sarcoma alliance for research through collaboration study 002 [corrected].

Maki RG, Wathen JK, Patel SR, Priebat DA, Okuno SH, Samuels B, Fanucchi M, Harmon DC, Schuetze SM, Reinke D, Thall PF, Benjamin RS, Baker LH, Hensley ML.

J Clin Oncol. 2007 Jul 1;25(19):2755-63. Erratum in: J Clin Oncol. 2007 Aug 20;25(24):3790.

PMID:
17602081
8.

Practical Bayesian adaptive randomisation in clinical trials.

Thall PF, Wathen JK.

Eur J Cancer. 2007 Mar;43(5):859-66. Epub 2007 Feb 16. Review.

9.

Adaptive allocation and failure saving in randomised clinical trials.

Bandyopadhyay U, Bhattacharya R.

J Biopharm Stat. 2006;16(6):817-29.

PMID:
17146981
10.

Bayesian clinical trials.

Berry DA.

Nat Rev Drug Discov. 2006 Jan;5(1):27-36. Review.

PMID:
16485344
11.

Design issues of randomized phase II trials and a proposal for phase II screening trials.

Rubinstein LV, Korn EL, Freidlin B, Hunsberger S, Ivy SP, Smith MA.

J Clin Oncol. 2005 Oct 1;23(28):7199-206.

PMID:
16192604
12.

Continuous Bayesian adaptive randomization based on event times with covariates.

Cheung YK, Inoue LY, Wathen JK, Thall PF.

Stat Med. 2006 Jan 15;25(1):55-70.

PMID:
16025549
13.

Statistical aspects of the analysis of data from retrospective studies of disease.

MANTEL N, HAENSZEL W.

J Natl Cancer Inst. 1959 Apr;22(4):719-48. No abstract available.

PMID:
13655060
14.

Adaptive randomized study of idarubicin and cytarabine versus troxacitabine and cytarabine versus troxacitabine and idarubicin in untreated patients 50 years or older with adverse karyotype acute myeloid leukemia.

Giles FJ, Kantarjian HM, Cortes JE, Garcia-Manero G, Verstovsek S, Faderl S, Thomas DA, Ferrajoli A, O'Brien S, Wathen JK, Xiao LC, Berry DA, Estey EH.

J Clin Oncol. 2003 May 1;21(9):1722-7.

PMID:
12721247
15.

Optimal adaptive designs for binary response trials.

Rosenberger WF, Stallard N, Ivanova A, Harper CN, Ricks ML.

Biometrics. 2001 Sep;57(3):909-13.

PMID:
11550944
16.
17.

Optimal allocation for the comparison of proportions.

Brittain E, Schlesselman JJ.

Biometrics. 1982 Dec;38(4):1003-9.

PMID:
7168791
18.

Allocation of subjects in medical experiments.

Weinstein MC.

N Engl J Med. 1974 Dec 12;291(24):1278-85. No abstract available.

PMID:
4610387
19.
20.

Randomized clinical trials. Perspectives on some recent ideas.

Byar DP, Simon RM, Friedewald WT, Schlesselman JJ, DeMets DL, Ellenberg JH, Gail MH, Ware JH.

N Engl J Med. 1976 Jul 8;295(2):74-80.

PMID:
775331

Supplemental Content

Support Center